JournalArta
Tuesday, November 17, 2026 · JakartaS&P 7,416.59 ▼1.92%USD/IDR 18,263 ▲0.07%
JournalArta
Global Edition
beyond headlines
Advertisement

Johnson & Johnson (JNJ) Stock Falls 1.12% (November 16, 2026): Up 11.3% in a Month

Technical analysis of JNJ stock on November 16, 2026: price 282.55 USD, trend uptrend, RSI 61.3, support 257.78, resistance 285.75.

By matthew jonathan
November 17, 20264 min read
Johnson & Johnson (JNJ) Stock Falls 1.12% (November 16, 2026): Up 11.3% in a Month
Logo Johnson & Johnson — JournalArta illustration

Why JNJ is in focus today

    Selected automatically from 8 NYSE (US) stocks by a technical-signal score with daily weighted randomisation — not a recommendation.

    Johnson & Johnson’s shares fell 1.12% to $282.55 on Monday, November 16, despite a broader technical uptrend that has lifted the stock 11.33% over the past month. The pullback puts the price near the top of its recent range, while a newly formed golden cross and rising trading volume point to continued underlying demand. The contrast matters to international investors: the chart remains constructive, but the latest quarterly filing shows a sharp fall in reported earnings. That makes the price trend and the company’s near-term fundamentals tell different stories.
    Advertisement

    Trend & Price Action

    Johnson & Johnson closed above both its 20-day moving average of $272.99 and its 50-day average of $267.01. The 20-day average rose 2.78% over five days, and it crossed above the 50-day average four sessions before the latest session. This “golden cross” is a common trend signal: it suggests recent price momentum has improved relative to the longer-term average, but does not guarantee further gains. The stock has gained 0.16% over five sessions and is up 11.33% in a month, despite the one-day decline. At 89% of its 20-session range, it is closer to resistance than support, leaving less room before a test of the recent ceiling. As shown in the chart, the key nearby reference points are the $257.78 support and $285.75 resistance; the three-month high is $290.25.
    Price action chart of JNJ
    3-month price action chart of JNJ: price, SMA20/50, Bollinger, support & resistance.
    Advertisement

    Oscillators & Momentum

    Momentum indicators remain broadly positive, though they do not show a uniformly accelerating move. The RSI is 61.3, a neutral reading: it indicates positive momentum without placing the stock in the conventional overbought zone. The Stochastic is neutral, with %K at 70.4 and %D at 83.0; its lower %K reading relative to %D is consistent with some cooling in short-term momentum. The MACD is positive: its 5.407 reading is above the 4.134 signal line, leaving a positive 1.273 histogram. In plain terms, the shorter-term trend still has upward momentum, even as the RSI is rolling over from above 65—a bearish signal recorded in the technical data. The indicators therefore support an uptrend, but argue against treating the latest advance as one-way.
    Momentum chart of JNJ
    Momentum chart of JNJ: RSI(14), MACD, Stochastic.
    Advertisement

    Volatility & Volume

    The share price sits at 80% of its Bollinger Band range, with bands at $257.24 and $288.74. The 11.5% band width is classified as normal, not unusually tight or expanded. Bollinger Bands measure how far prices have moved around a recent average; here, the position near the upper band reflects strength, while also showing that the stock is approaching a zone where it has recently faced pressure. Trading volume reached 8,101,700 shares, or 1.1 times the 20-session average of 7,419,880. On-balance volume (OBV), which tracks whether volume tends to accompany rising or falling prices, is increasing. That combination supports the bullish case: participation has been above normal and buying pressure is building, rather than the advance resting solely on thin trading. Average true range is $7.39, or 2.6% of the share price, indicating moderate day-to-day volatility.
    Advertisement

    Fundamental Context

    According to its SEC filing, Johnson & Johnson reported quarterly revenue of $25.40 billion for the quarter ended September 27, 2026, up 5.9% from $23.99 billion a year earlier. Net income, however, was $210.0 million, compared with $5.15 billion a year earlier, and diluted earnings per share were $0.09. The revenue increase signals continuing sales growth, but the earnings comparison is a marked weakness that technical indicators alone cannot explain.

    Technical Verdict: BUY

    The JournalArta Research verdict is BUY, with a score of +84 on a −100 to +100 scale. The strongest technical supports are the rising trend with price above its 50-day average, the 20-day average’s golden cross above the 50-day average, and rising OBV. The main caution is the RSI rolling over from above 65, alongside the stock’s proximity to resistance. The verdict is invalidated if the price falls below $269.96. - Ideal entry range: $277.00–$282.55 - Exit targets: $301.43 (Target 1) and $320.32 (Target 2) - Stop-loss protection: $269.96 - Validity: Until December 15, 2026 For non-traders, the verdict means the technical setup favors further gains, but a fall below the stated stop level would undermine that reading.
    Advertisement

    Summary Data JNJ

    Last price282.55 USD
    Change 1 day / 5 days / 1 month-1.12% / 0.16% / 11.33%
    Trend / MA-crossuptrend / golden
    SMA20 / SMA50272.99 / 267.01
    RSI (14) / Stochastic %K61.3 / 70.4
    Bollinger %B / ATR80% / 7.39
    Support / Resistance 20 days257.78 / 285.75
    Data as of17 November 2026 04:00 WIB
    JournalArta research verdict (score)Buy (+84)
    Entry zone277.00 – 282.55
    Target 1 / 2301.43 / 320.32
    Stop loss269.96
    Reward/risk1.5 / 3.0

    Disclaimer: This technical analysis is generated automatically from exchange data and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.

    Advertisement
    Take the quizWhat Kind of Holiday Spender Are You? Take the Black Friday QuizStart →
    Advertisement
    Most Read
    1. 1U.S. Emergency Alert Test Nov. 17 Is Not a Power Outage
    2. 2Women With Autoimmune Diseases Wait About 4 Years for Diagnosis, Study Finds
    3. 3DUP Chairman Lord Morrow Loses Wife and Daughter Within Hours in NI
    4. 4Micron Stock Falls 28% as $35.16 Billion Buyback Nears
    5. 5I’m A Celebrity 2026 Line-Up: Rooney Leads 11 Stars Into Jungle
    Advertisement
    Don't Miss

    Latest News

    All stories →
    1. Markets · CryptoIntesa Sanpaolo Adds XRP, Solana ETFs and Cuts BitcoinNov 17
    2. Business · CompaniesChase Customers Face Slow Transactions as Bank Outages SpreadNov 17
    3. Technology · AINvidia’s Madison Huang Lost Her Temper Before India AI SummitNov 17
    4. Lifestyle · EntertainmentKadiatu Kanneh-Mason Devastated by Nottingham Music ClosureNov 17
    5. Advertisement
    6. Lifestyle · EntertainmentSebastián Lelio Remembered for Films That Reached Beyond the EverydayNov 17
    7. Lifestyle · EntertainmentPrince William and Catherine Play Street Cricket in MumbaiNov 17
    8. World · United StatesMegaspeed Probe Began in 2024, US SaysNov 17
    9. Business · CompaniesKia Sorento Crosses 4,500 Wholesale Units in IndiaNov 17